221 related articles for article (PubMed ID: 16702405)
1. MOZ is essential for maintenance of hematopoietic stem cells.
Katsumoto T; Aikawa Y; Iwama A; Ueda S; Ichikawa H; Ochiya T; Kitabayashi I
Genes Dev; 2006 May; 20(10):1321-30. PubMed ID: 16702405
[TBL] [Abstract][Full Text] [Related]
2. Roles of the histone acetyltransferase monocytic leukemia zinc finger protein in normal and malignant hematopoiesis.
Katsumoto T; Yoshida N; Kitabayashi I
Cancer Sci; 2008 Aug; 99(8):1523-7. PubMed ID: 18754862
[TBL] [Abstract][Full Text] [Related]
3. Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.
Kitabayashi I; Aikawa Y; Nguyen LA; Yokoyama A; Ohki M
EMBO J; 2001 Dec; 20(24):7184-96. PubMed ID: 11742995
[TBL] [Abstract][Full Text] [Related]
4. PU.1 Mimic Synthetic Peptides Selectively Bind with GATA-1 and Allow c-Jun PU.1 Binding to Enhance Myelopoiesis.
Raghav PK; Gangenahalli G
Int J Nanomedicine; 2021; 16():3833-3859. PubMed ID: 34113102
[TBL] [Abstract][Full Text] [Related]
5. Coordinated changes in gene expression kinetics underlie both mouse and human erythroid maturation.
Barile M; Imaz-Rosshandler I; Inzani I; Ghazanfar S; Nichols J; Marioni JC; Guibentif C; Göttgens B
Genome Biol; 2021 Jul; 22(1):197. PubMed ID: 34225769
[TBL] [Abstract][Full Text] [Related]
6. Transient PU.1 low fetal progenitors generate lymphoid progeny that contribute to adult immunity.
Montecino-Rodriguez E; Estrada OI; Dorshkind K
Life Sci Alliance; 2024 Aug; 7(8):. PubMed ID: 38830768
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of Mpl marks the transition to lymphoid-primed multipotent progenitors with gradual loss of granulocyte-monocyte potential.
Luc S; Anderson K; Kharazi S; Buza-Vidas N; Böiers C; Jensen CT; Ma Z; Wittmann L; Jacobsen SE
Blood; 2008 Apr; 111(7):3424-34. PubMed ID: 18218856
[TBL] [Abstract][Full Text] [Related]
8. MORF and MOZ acetyltransferases target unmethylated CpG islands through the winged helix domain.
Becht DC; Klein BJ; Kanai A; Jang SM; Cox KL; Zhou BR; Phanor SK; Zhang Y; Chen RW; Ebmeier CC; Lachance C; Galloy M; Fradet-Turcotte A; Bulyk ML; Bai Y; Poirier MG; Côté J; Yokoyama A; Kutateladze TG
Nat Commun; 2023 Feb; 14(1):697. PubMed ID: 36754959
[TBL] [Abstract][Full Text] [Related]
9. Mutation accumulation and developmental lineages in normal and Down syndrome human fetal haematopoiesis.
Hasaart KAL; Manders F; van der Hoorn ML; Verheul M; Poplonski T; Kuijk E; de Sousa Lopes SMC; van Boxtel R
Sci Rep; 2020 Jul; 10(1):12991. PubMed ID: 32737409
[TBL] [Abstract][Full Text] [Related]
10. The MYSTerious MOZ, a histone acetyltransferase with a key role in haematopoiesis.
Perez-Campo FM; Costa G; Lie-a-Ling M; Kouskoff V; Lacaud G
Immunology; 2013 Jun; 139(2):161-5. PubMed ID: 23347099
[TBL] [Abstract][Full Text] [Related]
11. MOZ regulates B-cell progenitors and, consequently, Moz haploinsufficiency dramatically retards MYC-induced lymphoma development.
Sheikh BN; Lee SC; El-Saafin F; Vanyai HK; Hu Y; Pang SH; Grabow S; Strasser A; Nutt SL; Alexander WS; Smyth GK; Voss AK; Thomas T
Blood; 2015 Mar; 125(12):1910-21. PubMed ID: 25605372
[TBL] [Abstract][Full Text] [Related]
12. PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2.
Aikawa Y; Katsumoto T; Zhang P; Shima H; Shino M; Terui K; Ito E; Ohno H; Stanley ER; Singh H; Tenen DG; Kitabayashi I
Nat Med; 2010 May; 16(5):580-5, 1p following 585. PubMed ID: 20418886
[TBL] [Abstract][Full Text] [Related]
13. MOZ (MYST3, KAT6A) inhibits senescence via the INK4A-ARF pathway.
Sheikh BN; Phipson B; El-Saafin F; Vanyai HK; Downer NL; Bird MJ; Kueh AJ; May RE; Smyth GK; Voss AK; Thomas T
Oncogene; 2015 Nov; 34(47):5807-20. PubMed ID: 25772242
[TBL] [Abstract][Full Text] [Related]
14. MOZ and MORF acetyltransferases: Molecular interaction, animal development and human disease.
Yang XJ
Biochim Biophys Acta; 2015 Aug; 1853(8):1818-26. PubMed ID: 25920810
[TBL] [Abstract][Full Text] [Related]
15. Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.
Shima H; Yamagata K; Aikawa Y; Shino M; Koseki H; Shimada H; Kitabayashi I
Int J Hematol; 2014 Jan; 99(1):21-31. PubMed ID: 24258712
[TBL] [Abstract][Full Text] [Related]
16. Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.
Ullah M; Pelletier N; Xiao L; Zhao SP; Wang K; Degerny C; Tahmasebi S; Cayrou C; Doyon Y; Goh SL; Champagne N; Côté J; Yang XJ
Mol Cell Biol; 2008 Nov; 28(22):6828-43. PubMed ID: 18794358
[TBL] [Abstract][Full Text] [Related]
17. KAT6A deficiency impairs cognitive functions through suppressing RSPO2/Wnt signaling in hippocampal CA3.
Liu Y; Fan M; Yang J; Mihaljević L; Chen KH; Ye Y; Sun S; Qiu Z
Sci Adv; 2024 May; 10(20):eadm9326. PubMed ID: 38758792
[TBL] [Abstract][Full Text] [Related]
18. The histone acetyltransferase KAT6B is required for hematopoietic stem cell development and function.
Bergamasco MI; Ranathunga N; Abeysekera W; Li-Wai-Suen CSN; Garnham AL; Willis SN; McRae HM; Yang Y; D'Amico A; Di Rago L; Wilcox S; Nutt SL; Alexander WS; Smyth GK; Voss AK; Thomas T
Stem Cell Reports; 2024 Apr; 19(4):469-485. PubMed ID: 38518784
[TBL] [Abstract][Full Text] [Related]
19. Emerging Roles of Epigenetic Regulators in Maintaining Hematopoietic Stem Cell Homeostasis.
Wang H; Han Y; Qian P
Adv Exp Med Biol; 2023; 1442():29-44. PubMed ID: 38228957
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
